Skip to content

Clinical trials

Phase 2 Subarachnoid Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Subarachnoid Hemorrhage Phase: Phase 2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20051
20091
20102
20131
20143
20151
20162
20191
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated4
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Henry Ford Health System2
Hope Pharmaceuticals2
University of Florida2
Aditya S. Pandey, MD1
Daniel Raper, MBBS1
E. Sander Connolly1
Idorsia Pharmaceuticals Ltd.1
Indiana University1
Johns Hopkins University1
NoNO Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Subarachnoid Hemorrhage18
Vasospasm, Intracranial5
Intracranial Aneurysm4
Aneurysm3
Headache3
Brain Ischemia2
Cerebral Hemorrhage2
Stroke2
Hemorrhage1
Hemorrhagic Stroke1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.